0000921895-20-000902.txt : 20200324
0000921895-20-000902.hdr.sgml : 20200324
20200324205052
ACCESSION NUMBER: 0000921895-20-000902
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200320
FILED AS OF DATE: 20200324
DATE AS OF CHANGE: 20200324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deliargyris Efthymios
CENTRAL INDEX KEY: 0001751617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
FILM NUMBER: 20739792
MAIL ADDRESS:
STREET 1: C/O PLX PHARMA,INC.8285 EL RIO STREET
STREET 2: SUITE 210
CITY: HOUSTON
STATE: TX
ZIP: 77054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
4
1
form411577002del_03242020.xml
OWNERSHIP DOCUMENT
X0306
4
2020-03-20
0
0001497504
PLx Pharma Inc.
PLXP
0001751617
Deliargyris Efthymios
9 FISHERS LANE
SUITE E
SPARTA
NJ
07871
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
2.16
2020-03-20
4
A
0
60000
0
A
2030-03-20
Common Stock
60000
60000
D
Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.
/s/ Efthymios Deliargyris
2020-03-24